Literature DB >> 11727958

Altered expression and localization of PKC eta in human breast tumors.

P A Masso-Welch1, J S Winston, S Edge, K M Darcy, H Asch, M M Vaughan, M M Ip.   

Abstract

Protein kinase C (PKC) eta is a PKC isoform whose upregulation is associated with differentiation in many epithelial tissues, including the rat mammary gland. The purpose of this study was to examine whether PKC eta is altered, in expression or localization, in human breast cancer. Paraffin sections of 49 in situ breast lesions, 29 invasive breast tumors, and nine normal breast biopsies were examined for PKC eta expression by immunohistochemistry. Adjacent regions of normal epithelium, and in situ lesions that were present adjacent to invasive lesions were also analyzed. In normal epithelium, regardless of the presence of adjacent in situ or invasive lesions, PKC eta was present in the cytoplasm of the luminal epithelium, and increased in areas of normal lobular development, similar to normal rat mammary gland. PKC eta staining intensity was homogeneous in normal lobules, but heterogeneous in in situ and invasive lesions, being focally increased in cells with aberrant nuclear morphology. In situ lesions were similar to adjacent normal epithelium in average staining intensity, regardless of whether invasion was also present. However, the invasive lesions themselves were significantly decreased in staining intensity compared to adjacent in situ lesions. In addition, 75% of invasive breast cancer lesions showed decreased staining relative to adjacent normal epithelium, compared to 37% of in situ lesions. The invasive tumors which possessed high PKC eta staining were associated with positive lymph node status. These results demonstrate that quantitative and qualitative alterations in PKC eta occur in human breast cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727958     DOI: 10.1023/a:1012265703669

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

1.  PKC eta regulates occludin phosphorylation and epithelial tight junction integrity.

Authors:  Takuya Suzuki; Bertha C Elias; Ankur Seth; Le Shen; Jerrold R Turner; Francesco Giorgianni; Dominic Desiderio; Ramareddy Guntaka; Radhakrishna Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-29       Impact factor: 11.205

2.  Protein kinase Cη is targeted to lipid droplets.

Authors:  Michitaka Suzuki; Yuri Iio; Naoaki Saito; Toyoshi Fujimoto
Journal:  Histochem Cell Biol       Date:  2013-02-24       Impact factor: 4.304

3.  Novel regulation of protein kinase C-η.

Authors:  Deepanwita Pal; Shalini Persaud Outram; Alakananda Basu
Journal:  Biochem Biophys Res Commun       Date:  2012-08-07       Impact factor: 3.575

4.  Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.

Authors:  Anna C Pavlick; Jennifer Wu; John Roberts; Mark A Rosenthal; Anne Hamilton; Scott Wadler; Kathleen Farrell; Michelle Carr; David Fry; Anthony J Murgo; Ruth Oratz; Howard Hochster; Leonard Liebes; Franco Muggia
Journal:  Cancer Chemother Pharmacol       Date:  2009-02-17       Impact factor: 3.333

Review 5.  Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium.

Authors:  D Breitkreutz; L Braiman-Wiksman; N Daum; M F Denning; T Tennenbaum
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-28       Impact factor: 4.553

6.  Upregulation of PKCη by PKCε and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival.

Authors:  Deepanwita Pal; Shalini Persaud Outram; Alakananda Basu
Journal:  Biochim Biophys Acta       Date:  2013-04-04

7.  The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity.

Authors:  Elisabeth Ersvaer; Astrid Olsnes Kittang; Peter Hampson; Kristoffer Sand; Bjørn Tore Gjertsen; Janet M Lord; Oystein Bruserud
Journal:  Toxins (Basel)       Date:  2010-01-22       Impact factor: 4.546

8.  Protein kinase C Beta in the tumor microenvironment promotes mammary tumorigenesis.

Authors:  Julie A Wallace; Jason R Pitarresi; Nandini Sharma; Marilly Palettas; Maria C Cuitiño; Steven T Sizemore; Lianbo Yu; Allen Sanderlin; Thomas J Rosol; Kamal D Mehta; Gina M Sizemore; Michael C Ostrowski
Journal:  Front Oncol       Date:  2014-04-23       Impact factor: 6.244

Review 9.  ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation.

Authors:  Melanie Ehrlich; Cecilia Sanchez; Chunbo Shao; Rie Nishiyama; John Kehrl; Rork Kuick; Takeo Kubota; Samir M Hanash
Journal:  Autoimmunity       Date:  2008-05       Impact factor: 2.815

10.  Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors.

Authors:  Martin Sokol; Matthias Wabl; Irene Rius Ruiz; Finn Skou Pedersen
Journal:  Retrovirology       Date:  2014-05-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.